VEGF Polymorphisms are Associated With an Increasing Risk of Developing Renal Cell Carcinoma-Reference-Cited by-同舟云学术

VEGF Polymorphisms are Associated With an Increasing Risk of Developing Renal Cell Carcinoma

Published:2010-10 Issue:4 Volume:184 Page:1273-1278
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bruyère Franck¹,Hovens Christopher M.²,Marson Marie-Noëlle³⁴⁵,Faivre d'Arcier Benjamin¹,Costello Anthony J.²,Watier Hervé³⁴⁵,Linassier Claude⁶,Ohresser Marc⁴⁵

Affiliation:

1. Urology Department, CHRU de Tours, Tours, France

2. Departments of Urology and Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia

3. Immunology Laboratory, CHRU de Tours, Tours, France

4. Centre National de la Recherche Scientifique (Unités Mixtes de Recherche 6239 Genetics, Immunotherapy, Chemistry and Cancer), Tours, France

5. Université François-Rabelais de Tours, Tours, France

6. Medical Oncology Department, CHRU de Tours, Tours, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas;Na;J Urol,2003

2. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma;Rini;J Clin Oncol,2005

3. Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma;Abe;Tohoku J Exp Med,2002

4. Sunitinib in patients with metastatic renal cell carcinoma;Motzer;JAMA,2006

5. No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease;Willot;Pharmacogenet Genomics,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of VEGF-2549I/D promoter polymorphism with gastrointestinal tract cancer risk: a meta-analysis;Egyptian Journal of Medical Human Genetics;2024-06-17

2. The relationship between VEGF-460(T>C) polymorphism and cancer risk: A systematic review and meta-analysis based on 46 reports;Medicine;2023-06-30

3. Analysis of vascular endothelial growth factor (VEGF) insertion/deletion gene polymorphism and environmental risk factors in sample of Algerian population with neovascular age-related macular degeneration (nAMD);Annales de Biologie Clinique;2022-09-01

4. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis;Meta Gene;2022-02

5. USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A165b alternative splicing via regulating SRSF1 and SRPK1;Cancer Cell International;2021-09-20